MetaCap

Aspen Neuroscience Statistics

NASDAQ: ASPEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.42+0.03 (+0.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Aspen Neuroscience by the numbers

Aspen Neuroscience has a market capitalization of $361.2 million based on 29.08M shares outstanding. With trailing EPS of $-4.89, Aspen Neuroscience is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.3% below its 50-day average and 2.3% below its 200-day average.

Average daily trading volume is 352.42K shares, or about $4.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ASPE valuation vs. peer median

ASPE compared with the median of 8 peer companies
MetricASPEPeer medianDifference
Market cap$361.16M$360.39M+0%
Avg. volume352.42K1.63M-78%

Peer median across 8 companies: PEPG, PBYI, PHAT, CTNM, IRD, MPLT, AVTX, INO.

Valuation

Price and trading

Previous close
12.39
Open
12.24
Day range
12.17 – 13.19
52-week range
11.20 – 14.90
Beta
—
Volume
130.04K

Dividends and events

Additional statistics

Market Cap
361.16M
Eps
-4.89
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
14.90
Week52 Low
11.20
Avg Volume
352.42K
Shares Outstanding
29.08M
Ma50
12.72
Ma200
12.72
Pct From52w High
-16.64%
Pct From52w Low
10.89%

Related